Compare Stocks: PBM, CLNN, RYM, and IXHL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLNN Clene	$4.29 -2.1%	$4.57	$3.25 ▼ $13.50	$56.91M	0.95	143,029 shs	75,246 shs
IXHL Incannex Healthcare	$3.44 +1.5%	$3.29	$2.49 ▼ $19.71	$40.62M	6.97	90,590 shs	73,568 shs
PBM Psyence Biomedical	$6.31 +3.4%	$4.17	$1.92 ▼ $28.13	$13.99M	1.72	68,218 shs	293,841 shs
RYM RYTHM	$23.01 -2.0%	$22.01	$14.00 ▼ $53.65	$51.14M	9.44	14,114 shs	4,987 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLNN Clene	-2.05%	+11.14%	-3.16%	-25.91%	-29.90%
IXHL Incannex Healthcare	+1.47%	-9.47%	-4.97%	+7.50%	-82.93%
PBM Psyence Biomedical	+3.44%	+8.42%	+49.53%	+132.84%	-72.03%
RYM RYTHM	-1.96%	+10.20%	+0.07%	-15.99%	-39.19%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLNN Clene	$4.29 -2.1%	$4.57	$3.25 ▼ $13.50	$56.91M	0.95	143,029 shs	75,246 shs
IXHL Incannex Healthcare	$3.44 +1.5%	$3.29	$2.49 ▼ $19.71	$40.62M	6.97	90,590 shs	73,568 shs
PBM Psyence Biomedical	$6.31 +3.4%	$4.17	$1.92 ▼ $28.13	$13.99M	1.72	68,218 shs	293,841 shs
RYM RYTHM	$23.01 -2.0%	$22.01	$14.00 ▼ $53.65	$51.14M	9.44	14,114 shs	4,987 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLNN Clene	-2.05%	+11.14%	-3.16%	-25.91%	-29.90%
IXHL Incannex Healthcare	+1.47%	-9.47%	-4.97%	+7.50%	-82.93%
PBM Psyence Biomedical	+3.44%	+8.42%	+49.53%	+132.84%	-72.03%
RYM RYTHM	-1.96%	+10.20%	+0.07%	-15.99%	-39.19%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLNN Clene	2.71	Moderate Buy	$34.00	692.54% Upside
IXHL Incannex Healthcare	2.00	Hold	$18.00	423.26% Upside
PBM Psyence Biomedical	1.00	Sell	N/A	N/A
RYM RYTHM	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest PBM, CLNN, RYM, and IXHL Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/10/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/27/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/17/2026	CLNN Clene	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/13/2026	RYM RYTHM	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/30/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/17/2026	IXHL Incannex Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	PBM Psyence Biomedical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/15/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/26/2026	CLNN Clene	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLNN Clene	$197K	282.97	N/A	N/A	($1.62) per share	-2.65
IXHL Incannex Healthcare	$90K	457.52	N/A	N/A	$2.07 per share	1.66
PBM Psyence Biomedical	N/A	N/A	N/A	N/A	$7.39 per share	N/A
RYM RYTHM	$17.28M	2.90	N/A	N/A	$6.06 per share	3.80

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLNN Clene	-$26.17M	-$3.50	N/A	N/A	N/A	-20,063.96%	N/A	-137.04%	11/12/2026 (Estimated)
IXHL Incannex Healthcare	-$46.88M	-$1.55	N/A	N/A	N/A	N/A	-81.01%	-76.11%	9/24/2026 (Estimated)
PBM Psyence Biomedical	-$6.94M	$25.34	0.25	N/A	N/A	N/A	N/A	N/A	N/A
RYM RYTHM	-$33.26M	-$10.53	N/A	N/A	N/A	-6.20%	-12.57%	-2.60%	N/A

Latest PBM, CLNN, RYM, and IXHL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/24/2026	Q4 2026	IXHL Incannex Healthcare	$0.13	N/A	N/A	N/A	$0.20 million	N/A
8/14/2026	Q2 2026	CLNN Clene	-$0.3680	-$1.08	-$0.7120	-$1.08	$0.06 million	$0.09 million
8/4/2026	Q2 2026	RYM RYTHM	N/A	$0.09	N/A	$0.09	N/A	$23.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLNN Clene	N/A	N/A	N/A	N/A	N/A
IXHL Incannex Healthcare	N/A	N/A	N/A	N/A	N/A
PBM Psyence Biomedical	N/A	N/A	N/A	N/A	N/A
RYM RYTHM	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLNN Clene	N/A	3.07	3.07
IXHL Incannex Healthcare	N/A	41.56	41.56
PBM Psyence Biomedical	N/A	14.62	14.62
RYM RYTHM	N/A	0.59	0.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLNN Clene	23.28%
IXHL Incannex Healthcare	0.43%
PBM Psyence Biomedical	77.44%
RYM RYTHM	5.98%

Insider Ownership

Company	Insider Ownership
CLNN Clene	28.30%
IXHL Incannex Healthcare	1.33%
PBM Psyence Biomedical	3.60%
RYM RYTHM	3.48%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLNN Clene	79	12.99 million	9.32 million	No Data
IXHL Incannex Healthcare	12	11.97 million	11.81 million	Not Optionable
PBM Psyence Biomedical	12	2.29 million	2.21 million	N/A
RYM RYTHM	141	2.18 million	2.10 million	N/A

PBM, CLNN, RYM, and IXHL Headlines

Recent News About These Companies

RYTHM (RYM) & Its Rivals Critical Analysis

3 hours ago | americanbankingnews.com

Financial Contrast: RYTHM (NASDAQ:RYM) and Fortress Biotech (NASDAQ:FBIO)

September 21 at 2:15 AM | americanbankingnews.com

Financial Review: RYTHM (RYM) and Its Competitors

September 20, 2026 | americanbankingnews.com

RYTHM (NASDAQ:RYM) Shares Up 2% - What's Next?

August 26, 2026 | marketbeat.com

RYTHM Introduces Lifted Lemon, a New THC Twist on Iced Tea and Lemonade

August 20, 2026 | globenewswire.com

RYTHM Inc

August 19, 2026 | markets.ft.com

RYTHM Shareholders Approve Dilutive Equity Issuance Changes

August 11, 2026 | tipranks.com

RYTHM Swings to Earnings in Q2 on THC Beverage Growth

August 7, 2026 | zacks.com

RYTHM, Inc. Reports Record Second-Quarter 2026 Revenue Growth and Strong THC Beverage Momentum

August 4, 2026 | quiverquant.comQ

RYTHM, Inc. Reports Second Quarter 2026 Results

August 4, 2026 | globenewswire.com

RYTHM (NASDAQ:RYM) Trading Up 14% – Time to Buy?

August 4, 2026 | defenseworld.netD

RYTHM, Inc. (RYM) Stock Major Holders - Yahoo Finance

July 27, 2026 | ca.finance.yahoo.com

Señorita Brings THC Beverages to Lollapalooza for the First Time

July 23, 2026 | globenewswire.com

Rythm Stock Short Interest Report | NASDAQ:RYM | Benzinga

July 17, 2026 | benzinga.com

RYTHM (NASDAQ:RYM) Director Sells 2,250 Shares

June 19, 2026 | insidertrades.com

RYTHM Inc.

May 16, 2026 | marketwatch.com

Señorita Named Official THC Beverage Partner of Opry Entertainment Group Venues

May 14, 2026 | globenewswire.com

Rythm Inc Ordinary Shares RYM

May 13, 2026 | morningstar.comM

RYTHM Stock Price History

May 12, 2026 | investing.com

RYTHM's Q1 Earnings Rise Y/Y on Licensing Agreement Benefits

May 11, 2026 | zacks.com

Navy Pier Names RYTHM as Its Official THC Beverage Partner

May 8, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBM, CLNN, RYM, and IXHL Company Descriptions

Clene NASDAQ:CLNN

$4.29 -0.09 (-2.05%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$4.32 +0.04 (+0.82%)

As of 09/23/2026 07:37 PM Eastern

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Incannex Healthcare NASDAQ:IXHL

$3.44 +0.05 (+1.47%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.42 -0.02 (-0.73%)

As of 05:17 AM Eastern

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. Incannex Healthcare Inc. was incorporated in 2001 and is based in Sydney, Australia.

Psyence Biomedical NASDAQ:PBM

$6.31 +0.21 (+3.44%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$6.42 +0.12 (+1.82%)

As of 05:42 AM Eastern

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.

RYTHM NASDAQ:RYM

$23.01 -0.46 (-1.96%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$22.98 -0.03 (-0.13%)

As of 09/23/2026 07:30 PM Eastern

Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PBM, CLNN, RYM, and IXHL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PBM, CLNN, RYM, and IXHL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PBM, CLNN, RYM, and IXHL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBM, CLNN, RYM, and IXHL Company Descriptions

Clene NASDAQ:CLNN

Incannex Healthcare NASDAQ:IXHL

Psyence Biomedical NASDAQ:PBM

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PBM, CLNN, RYM, and IXHL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PBM, CLNN, RYM, and IXHL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PBM, CLNN, RYM, and IXHL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PBM, CLNN, RYM, and IXHL Company Descriptions

Clene NASDAQ:CLNN

Incannex Healthcare NASDAQ:IXHL

Psyence Biomedical NASDAQ:PBM

RYTHM NASDAQ:RYM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools